Biocartis Group N.V.

BIOGF · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$65-$71-$63-$64
Dep. & Amort.$10$10$10$10
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$1
Change in WC-$4-$10$3-$4
Other Non-Cash$18$8$16$8
Operating Cash Flow-$45-$66-$39-$54
Investing Activities
PP&E Inv.-$2-$4-$3-$3
Net Acquisitions-$1$0-$1-$3
Inv. Purchases-$3$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0-$0-$0-$0
Investing Cash Flow-$5-$4-$4-$5
Financing Activities
Debt Repay.-$1-$1-$7$122
Stock Issued$23$0$0$53
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$4-$0
Financing Cash Flow$22-$1-$12$175
Forex Effect$0$1-$0-$0
Net Chg. in Cash-$27-$70-$55$115
Supplemental Information
Beg. Cash$54$124$179$64
End Cash$26$54$124$179
Free Cash Flow-$47-$69-$42-$57